ストックスクリーナーアプリを入手
29.93
1.64%
-0.50
プレマーケット:
30.00
0.07
+0.23%
前日終値:
$30.43
開ける：
$30.31
24時間の取引高:
3.23M
Relative Volume:
0.67
時価総額：
$15.28B
収益：
$17.28B
当期純損益:
$108.00M
株価収益率:
149.65
EPS:
0.2
ネットキャッシュフロー:
$391.00M
1週間 パフォーマンス:
-3.39%
1か月 パフォーマンス:
+3.96%
6か月 パフォーマンス:
-17.11%
1年 パフォーマンス:
-18.02%
1日の値動き範囲:
$29.86
$30.51
1週間の範囲:
$29.86
$32.60
52週間の値動き範囲:
$26.25
$40.49
Baxter International Inc Stock (BAX) Company Profile
名前
Baxter International Inc
セクター
電話
(847) 948-2000
住所
ONE BAXTER PKWY, DEERFIELD, IL
BAX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
29.93 | 15.28B | 17.28B | 108.00M | 391.00M | 0.20 |
|
ISRG
Intuitive Surgical Inc
|
530.46 | 184.55B | 8.71B | 2.48B | 1.75B | 6.82 |
|
ALC
Alcon Inc
|
95.99 | 47.69B | 9.91B | 1.02B | 665.00M | 2.05 |
|
BDX
Becton Dickinson Co
|
165.15 | 47.42B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
241.95 | 34.86B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
80.57 | 16.05B | 3.90B | 392.30M | 288.10M | 1.95 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-26 | 再開されました | Goldman | Buy |
| 2025-02-24 | アップグレード | Argus | Hold → Buy |
| 2025-02-20 | 再開されました | Barclays | Overweight |
| 2024-07-15 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | 開始されました | Goldman | Neutral |
| 2024-05-10 | ダウングレード | TD Cowen | Buy → Hold |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-12-19 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-12-15 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-12-12 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-06-24 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | ダウングレード | Goldman | Neutral → Sell |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-18 | 繰り返されました | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-02-18 | 繰り返されました | Raymond James | Outperform |
| 2022-02-18 | 繰り返されました | Stifel | Buy |
| 2022-02-18 | 繰り返されました | UBS | Neutral |
| 2022-02-18 | 繰り返されました | Wells Fargo | Overweight |
| 2022-02-11 | 開始されました | Goldman | Neutral |
| 2022-01-07 | 再開されました | Citigroup | Buy |
| 2022-01-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | アップグレード | Cowen | Market Perform → Outperform |
| 2021-09-03 | アップグレード | Barclays | Equal Weight → Overweight |
| 2021-05-25 | 開始されました | Barclays | Equal Weight |
| 2021-01-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | ダウングレード | UBS | Buy → Neutral |
| 2020-12-15 | ダウングレード | Goldman | Buy → Neutral |
| 2020-10-01 | アップグレード | Citigroup | Neutral → Buy |
| 2020-09-04 | ダウングレード | Argus | Buy → Hold |
| 2020-06-24 | 開始されました | Oppenheimer | Outperform |
| 2020-03-19 | アップグレード | Stifel | Hold → Buy |
| 2020-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-13 | 開始されました | Goldman | Buy |
| 2020-01-02 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-12-17 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-01-02 | アップグレード | Citigroup | Neutral → Buy |
| 2019-01-02 | アップグレード | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | アップグレード | Argus | Hold → Buy |
| 2018-10-16 | 開始されました | Barclays | Underweight |
| 2018-05-17 | 再開されました | Piper Jaffray | Overweight |
| 2018-02-06 | 繰り返されました | Citigroup | Neutral |
| 2018-01-03 | 開始されました | Evercore ISI | Outperform |
| 2018-01-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
すべてを表示
Baxter International Inc (BAX) 最新ニュース
Beyond the Balance Sheet: What SWOT Reveals About Baxter Interna - GuruFocus
Baxter International IncDeclares Quarterly Dividend Of $0.17 Per Share - marketscreener.com
Baxter Declares Quarterly Dividend | BAX Stock News - GuruFocus
Baxter Declares Quarterly Dividend - Bluefield Daily Telegraph
Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says - AOL.com
What Are Wall Street Analysts' Target Price For Baxter International Stock? - Barchart.com
Baxter stock rises on earnings beat, guidance raise - MSN
Baxter International Inc. (NYSE:BAX) Q1 2025 Earnings Call Transcript - Insider Monkey
Health care company says Trump tariffs will cost it $60M–$70M this year - Ars Technica
Baxter International Inc. (NYSE:BAX) Shares Sold by Banco Bilbao Vizcaya Argentaria S.A. - MarketBeat
Baxter Intl (BAX): Wells Fargo Lowers Price Target to $33 | BAX Stock News - GuruFocus
Baxter (BAX) Target Price Reduced by Stifel Amid Strong Q1 Results | BAX Stock News - GuruFocus
Wells Fargo Adjusts Baxter International Price Target to $33 From $36 - marketscreener.com
Citigroup Adjusts Price Target on Baxter International to $34 From $35 - marketscreener.com
JPMorgan Adjusts Price Target on Baxter International to $34 From $36 - marketscreener.com
Here's Why Baxter International (NYSE:BAX) Has A Meaningful Debt Burden - simplywall.st
Press Release Distribution & PR Platform - ACCESS Newswire
Baxter International Inc (BAX) Q1 2025 Earnings Call Highlights: Strong Sales Growth and EPS ... - Yahoo
Baxter International Inc (BAX) Q1 2025 Earnings Call Highlights: Strong Sales Growth and EPS Surpass Expectations - GuruFocus
Baxter International Reports Strong Q1 2025 Results - TipRanks
State of Tennessee Department of Treasury Sells 69,945 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International Surpasses Q1 2025 Expectations - TipRanks
Baxter International, Deerfield-based maker of IV fluid and pharmaceuticals, expects tariff impact of $60 to $70M - Chicago Tribune
Balanced Outlook on Baxter International: Strong Performance with Margin Concerns - TipRanks
Baxter International Inc. 2025 Q1ResultsEarnings Call Presentation (NYSE:BAX) - Seeking Alpha
Baxter Earnings: Elevated Medical Utilization Mildly Boosts 2025 Outlook Despite Tariff Concerns - Morningstar
Baxter Still in Turnaround Mode Following Weak Postpandemic Results and Renal Divestiture - Morningstar
Evercore ISI Adjusts Baxter International Price Target to $44 From $45, Maintains Outperform Rating - marketscreener.com
Baxter International (BAX) Stock Climbs on Strong Earnings and R - GuruFocus
BAX Stock Gains Following Q1 Earnings Beat Estimates, Revenues Up Y/Y - TradingView
Baxter Reports Strong Medical Devices Sales In Q1, Lifts 2025 Guidance, Stock Jumps - Benzinga
Baxter stock rises on earnings beat, guidance raise (BAX:NYSE) - Seeking Alpha
Baxter International Surpasses Revenue Expectations in Q1 2025News and Statistics - IndexBox
Earnings call transcript: Baxter International beats Q1 2025 expectations - Investing.com
Earnings call transcript: Baxter International beats Q1 2025 expectations By Investing.com - Investing.com India
Baxter’s (NYSE:BAX) Q1: Beats On Revenue - Yahoo Finance
Baxter (BAX) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Baxter posts strong U.S. sales, anticipates $60M hit from tariffs - Crain's Chicago Business
Baxter (BAX) Surpasses Q1 Revenue Forecast Amid Strategic Transf - GuruFocus
Baxter (BAX) Updates Sales and Earnings Outlook | BAX Stock News - GuruFocus
Baxter tops quarterly estimates on strong demand for medical devices - TradingView
Baxter International's Q1 Adjusted Net Income Drops, Revenue Rises; Full-Year 2025 Guidance Revised - marketscreener.com
Baxter Q1 2025 slides: Sales beat expectations, EPS surges 53%, guidance raised - Investing.com Australia
Baxter International Inc Surpasses Q1 2025 Estimates with $0.55 EPS and $2.63 Billion Revenue - GuruFocus
Baxter Reports First-Quarter 2025 Results - Baxter
Baxter Reports First-Quarter 2025 Results | BAX Stock News - GuruFocus
Baxter International Boosts FY25 OutlookUpdate - Nasdaq
Baxter International Inc. Q1 Profit Increases, Beats Estimates - Nasdaq
Baxter shares rise as Q1 earnings top estimates, guidance raised - Investing.com Australia
Baxter shares rise as Q1 earnings top estimates, guidance raised By Investing.com - Investing.com India
Baxter International Inc. Reports First-Quarter 2025 Results - TradingView
Baxter International Inc (BAX) 財務データ
収益
当期純利益
現金流量
EPS
2.66%
0.72%
大文字化:
|
ボリューム (24 時間):